Sino Biopharmaceutical Dividend
Dividend criteria checks 2/6
Sino Biopharmaceutical is a dividend paying company with a current yield of 1.86% that is well covered by earnings. Next payment date is on 5th July, 2024 with an ex-dividend date of 11th June, 2024.
Key information
1.9%
Dividend yield
46%
Payout ratio
| Industry average yield | 3.7% |
| Next dividend pay date | 05 Jul 24 |
| Ex dividend date | 11 Jun 24 |
| Dividend per share | n/a |
| Earnings per share | HK$0.10 |
| Dividend yield forecast in 3Y | 2.9% |
Recent dividend updates
Recent updates
Sino Biopharmaceutical Limited's (HKG:1177) 27% Cheaper Price Remains In Tune With Earnings
Apr 21
What Does The Future Hold For Sino Biopharmaceutical Limited (HKG:1177)? These Analysts Have Been Cutting Their Estimates
Apr 03Sino Biopharmaceutical Limited's (HKG:1177) Intrinsic Value Is Potentially 34% Above Its Share Price
Mar 20Sino Biopharmaceutical Limited's (HKG:1177) Shares May Have Run Too Fast Too Soon
Dec 18Does Sino Biopharmaceutical (HKG:1177) Have A Healthy Balance Sheet?
Dec 02Sino Biopharmaceutical Limited (HKG:1177) Shares Could Be 41% Below Their Intrinsic Value Estimate
Nov 17We Think Sino Biopharmaceutical (HKG:1177) Can Manage Its Debt With Ease
Aug 30Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 50% Undervaluation?
May 26Sino Biopharmaceutical (HKG:1177) Has A Rock Solid Balance Sheet
Apr 20Is Sino Biopharmaceutical Limited (HKG:1177) Trading At A 38% Discount?
Feb 09Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 41% Undervaluation?
Nov 11Sino Biopharmaceutical (HKG:1177) Seems To Use Debt Quite Sensibly
Oct 24Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 46% Undervaluation?
Jul 08Is Sino Biopharmaceutical (HKG:1177) Using Too Much Debt?
Apr 28An Intrinsic Calculation For Sino Biopharmaceutical Limited (HKG:1177) Suggests It's 45% Undervalued
Jan 22Sino Biopharmaceutical (HKG:1177) Has A Pretty Healthy Balance Sheet
Dec 03Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 41% Undervaluation?
Oct 19Sino Biopharmaceutical (HKG:1177) Has Re-Affirmed Its Dividend Of HK$0.02
Sep 03These 4 Measures Indicate That Sino Biopharmaceutical (HKG:1177) Is Using Debt Reasonably Well
Aug 27Is There An Opportunity With Sino Biopharmaceutical Limited's (HKG:1177) 38% Undervaluation?
Jul 14Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 1177's dividend payments have been volatile in the past 10 years.
Growing Dividend: 1177's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Sino Biopharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (1177) | 1.9% |
| Market Bottom 25% (HK) | 3.4% |
| Market Top 25% (HK) | 8.3% |
| Industry Average (Pharmaceuticals) | 3.7% |
| Analyst forecast in 3 Years (1177) | 2.9% |
Notable Dividend: 1177's dividend (1.86%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.45%).
High Dividend: 1177's dividend (1.86%) is low compared to the top 25% of dividend payers in the Hong Kong market (8.26%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (45.5%), 1177's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Insufficient data to calculate 1177's cash payout ratio to determine if its dividend payments are covered by cash flows.